Acuitas: (noun) insight, perception, sharpness.

OUR HISTORY

Founded in February 2009, Acuitas Therapeutics is a private company incorporated in British Columbia, Canada.

KEY CAPABILITIES INCLUDE

Proven ability to design and synthesize key LNP components

In vivo screening to select LNP therapeutic candidates

State of the art models to characterize LNP therapeutics

Experienced staff to advance products from R&D into clinical development

Excellent communication and project management skills

We were founded in February 2009 and have partnered with Alnylam Pharmaceuticals, the University of British Columbia, IRAP and others on several research and development programs relating to systemic delivery of nucleic acid therapeutics.

Acuitas Therapeutics is a private company incorporated in British Columbia, Canada. We were founded in February 2009 (initially as AlCana Technologies) and have partnered with Alnylam Pharmaceuticals, the University of British Columbia, IRAP and others on several research and development programs relating to systemic delivery of nucleic acid therapeutics.

We work with partners and thought-leaders to advance nucleic acid therapeutics into clinical development. Our goal is to apply nanotechnology delivery solutions to improve the therapeutic options available to patients.